Biogen Pharmachem Industries Limited (BOM:531752)

BOM:531752 Revenue

Biogen Pharmachem Industries had revenue of 15.43M INR in the quarter ending June 30, 2025, a decrease of -1,797.25%. This brings the company's revenue in the last twelve months to 16.34M, up 6.26% year-over-year. In the fiscal year ending March 31, 2025, Biogen Pharmachem Industries had annual revenue of 11.98M with 51.78% growth.

• Revenue (ttm): 16.34M
• Revenue Growth: +6.26%
• P/S Ratio: 33.55
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 548.19M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	11.98M	4.09M	51.78%
Mar 31, 2024	7.89M	5.39M	215.26%
Mar 31, 2023	2.50M	-22.31M	-89.91%
Mar 31, 2022	24.81M	8.58M	52.90%
Mar 31, 2021	16.23M	-	-